• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

arthritis

Moon Lake
Biotech

MoonLake arthritis win kicks off pivotal year for IL-17 nanobody

MoonLake has kicked off a year of readouts for its much-hyped inflammatory disease prospect with a midstage win in a type of arthritis.
James Waldron Feb 23, 2026 5:10am
UCB logo on flag

UCB's bispecific notches phase 3 win for spinal arthritis

Jan 18, 2022 10:21am
Stethoscope on dollars

Acelyrin snags $250M, licenses Affibody IL-17 asset for 3 trials

Nov 16, 2021 5:00am
Ada Health assessment

Novartis adds AI-based diagnostic surveys to online disease hubs

May 13, 2021 3:40pm
Novartis headquarters

Novartis’ Ilaris cuts rate of joint replacements from arthritis

Aug 3, 2020 5:00pm
Gilead

Gilead builds case for filgotinib in active psoriatic arthritis

Jun 8, 2020 8:10am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings